We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.27%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$86.3B
AUM Growth
-$7.68B
(-8.2%)
Cap. Flow
-$13B
Cap. Flow
% of AUM
-15.06%
Top 10 Holdings %
Top 10 Hldgs %
22.87%
Holding
2,645
New
347
Increased
664
Reduced
827
Closed
297
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$198M |
| 2 |
PayPal
PYPL
|
+$179M |
| 3 |
Vail Resorts
MTN
|
+$177M |
| 4 |
HEICO Corp
HEI
|
+$160M |
| 5 |
S&P Global
SPGI
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$350M |
| 2 |
CDW
CDW
|
+$280M |
| 3 |
Alibaba
BABA
|
+$258M |
| 4 |
Public Storage
PSA
|
+$247M |
| 5 |
Labcorp
LH
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.85% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 13.92% |
| 4 | Industrials | 9.55% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Concentrix
CNXC
$1.57B
| $304K | ﹤0.01% |
1,830
+632
| +53% | +$120K |
|
977
Tandem Diabetes Care
TNDM
$1.56B
| $304K | ﹤0.01% |
2,616
+1,663
| +175% | +$194K |
|
978
CME Group
CME
$94.8B
| $303K | ﹤0.01% |
1,277
+21
| +2% | +$4.93K |
|
979
Mesa Laboratories
MLAB
$574M
| $301K | ﹤0.01% |
1,183
-4,387
| -79% | -$1.19M |
|
980
Fiverr
FVRR
$339M
| $296K | ﹤0.01% |
3,900
+1,488
| +62% | +$118K |
|
981
Coherus Oncology
CHRS
$196M
| $295K | ﹤0.01% |
22,888
-23,486
| -51% | -$299K |
|
|
BHR
982
Braemar Hotels & Resorts
BHR
$142M
| $293K | ﹤0.01% |
47,448
+75
| +0.2% | +$429 |
|
983
Quest Diagnostics
DGX
$26.3B
| $289K | ﹤0.01% |
2,124
-128,229
| -98% | -$17.9M |
|
984
Boeing
BA
$185B
| $287K | ﹤0.01% |
1,500
| – | – |
|
985
AngloGold Ashanti
AU
$48.7B
| $286K | ﹤0.01% |
+12,100
| New | +$263K |
|
986
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$312M
| – | – |
0
| – | – |
|
987
Willis Towers Watson
WTW
$32B
| $285K | ﹤0.01% |
1,209
+70
| +6% | +$16K |
|
988
Howmet Aerospace
HWM
$112B
| $281K | ﹤0.01% |
7,844
+590
| +8% | +$20.1K |
|
989
Hexcel
HXL
$7.82B
| $281K | ﹤0.01% |
4,740
-265
| -5% | -$14.6K |
|
990
Applovin
APP
$116B
| $275K | ﹤0.01% |
+5,000
| New | +$318K |
|
|
BGB
991
Blackstone Strategic Credit 2027 Term Fund
BGB
$503M
| – | – |
0
| – | – |
|
992
Camtek
CAMT
$7.25B
| $273K | ﹤0.01% |
8,979
-733
| -8% | -$25.8K |
|
|
RADI
993
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $272K | ﹤0.01% |
19,062
-9,272
| -33% | -$129K |
|
994
Danaos Corp
DAC
$2.56B
| $271K | ﹤0.01% |
2,645
-429
| -14% | -$39K |
|
995
Playtika
PLTK
$1.12B
| $269K | ﹤0.01% |
13,936
-71,074
| -84% | -$1.27M |
|
996
Choice Hotels
CHH
$4.8B
| $264K | ﹤0.01% |
1,868
+1,796
| +2,494% | +$258K |
|
997
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.62B
| – | – |
0
| – | – |
|
|
ESPR
998
DELISTED
Esperion Therapeutics
ESPR
| $261K | ﹤0.01% |
56,427
+20,136
| +55% | +$86.4K |
|
999
Ally Financial
ALLY
$13.3B
| $260K | ﹤0.01% |
6,012
-2,638
| -30% | -$125K |
|
1000
Omeros
OMER
$959M
| $259K | ﹤0.01% |
43,192
+4,286
| +11% | +$26.7K |
|
Similar funds
QCM
Lazard Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, Lazard Asset Management held 2,645 positions worth $86.3B, down 8.2% from $94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $13B in Q1 2022, closing 297 positions and reducing 827 holdings. Its most notable exit was Stericycle Inc, an estimated $70.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Lazard Asset Management opened a new position in Vail Resorts worth $169M.
- Lazard Asset Management's largest Q1 2022 buy was Vail Resorts: 649,949 shares worth $169M.
- Lazard Asset Management added most to Nike in Q1 2022, an estimated $198M increase.
- Lazard Asset Management's biggest Q1 2022 reduction was Medtronic, cutting an estimated $350M.
- Lazard Asset Management fully exited Stericycle Inc in Q1 2022, selling an estimated $70.3M.
- Lazard Asset Management's ten largest holdings make up 23% of its $86.3B portfolio in Q1 2022.
- Lazard Asset Management opened 347 new positions and closed 297 in Q1 2022.
- Lazard Asset Management's portfolio value fell 8.2% quarter-over-quarter to $86.3B.
Based on Lazard Asset Management's 13F filing for Q1 2022, filed 13 May 2022.